1992
DOI: 10.1172/jci116046
|View full text |Cite
|
Sign up to set email alerts
|

Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.

Abstract: A human ovarian small cell carcinoma line (BIN-67) expresses abundant calcitonin (CT) receptors (CTR) (143,000 per cell) that are coupled, to adenylate cyclase. The dissociation constants (Kd) for the CTrRs on these BIN-67 cells is -0.42 nM for salmon Cl and -4.6 nM for human CT. To clone a human CTR (hCTR), a BIN-67 cDNA library was screened using a cDNA probe from a porcine renal CTR (pClR) that we recently cloned. One positive clone of 3,588 bp was identified. Transfection of this cDNA into COS cells result… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
74
0
1

Year Published

1994
1994
2011
2011

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 190 publications
(78 citation statements)
references
References 49 publications
3
74
0
1
Order By: Relevance
“…These data are consistent with photocross-linking to the amino terminus of the mutant receptor with cleavage at Met 49 and confirm Met 49 as the site of cross-linking for [Bpa 8 ]sCT (8 -32) (Fig. 7C) 19 ]sCT (8 -32) efficiently labeled the HA-hCTR a receptor transiently expressed in COS-7 cells with a single radioactive band of M r ϳ97,000, which shifted to M r ϳ52,000 after Nglycosidase F deglycosylation (Fig. 8A).…”
Section: Pharmacological Characterization Of the Antagonist Peptidesupporting
confidence: 84%
See 2 more Smart Citations
“…These data are consistent with photocross-linking to the amino terminus of the mutant receptor with cleavage at Met 49 and confirm Met 49 as the site of cross-linking for [Bpa 8 ]sCT (8 -32) (Fig. 7C) 19 ]sCT (8 -32) efficiently labeled the HA-hCTR a receptor transiently expressed in COS-7 cells with a single radioactive band of M r ϳ97,000, which shifted to M r ϳ52,000 after Nglycosidase F deglycosylation (Fig. 8A).…”
Section: Pharmacological Characterization Of the Antagonist Peptidesupporting
confidence: 84%
“…Antagonism of hCT-induced cAMP production by sCT (8 -32) Fig. 2, BϪD 19 ]sCT(8 -32)) with high affinity, similar to that seen for unmodified sCT (Fig. 3, A and B).…”
Section: Pharmacological Characterization Of the Antagonist Peptidesupporting
confidence: 62%
See 1 more Smart Citation
“…[23][24][25][26] CT binds two G-protein-coupled receptors in humans: CT receptor types 1 (CT (A) ) and 2 (CT (B) ). [27][28][29] CT (A) and CT (B) are both associated with the heterotrimeric G-protein Gs and increase intracellular cAMP, but CT (B) can also affect phosphoinositide-specific phospholipase C. 30 Although CT affects several organs, its principal target is the kidney where it is largely degraded. [31][32][33][34][35][36] The distribution of CT-binding sites is slightly different among rat, mouse, rabbit, primate, and human.…”
mentioning
confidence: 99%
“…When translation initiates in E3a, it is possible that the N terminus of mCTR is cytoplasmic, with the adjacent sequence of hydrophobic residues forming an additional eighth transmembrane domain. Like mCTR, the hCTR mRNA has also been reported to contain two putative translation start sites (17), and the upstream start is contained within a variably spliced 71-bp exon (24). The translation product initiated from the hCTR upstream start site is 18 amino acids longer than if initiated from the downstream start site.…”
Section: Discussionmentioning
confidence: 99%